Hydroxylamine nitric oxide donors for thermally induced delivery of inhalable nitric oxide
Thermo-responsive nitric oxide releasing compounds address the limitations of current iNO delivery systems by enabling portable, stable, and safe NO delivery for pulmonary disorders and antimicrobial uses.
Patent Information
- Application Number
- PCT/US2025/035801
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-06-28
- Filing Date
- 2025-06-27
- Publication Date
- 2026-01-02
AI Technical Summary
Current iNO delivery systems are costly, difficult to transport, and dangerous, limiting their use to controlled hospital settings, and alternative on-demand systems face challenges with portability, NO purity, and stability, especially when using toxic and/or explosive NO precursors.
Development of thermo-responsive nitric oxide releasing compounds based on N-trityl 3,6-dihydro-1,2-oxazines and allyl hydroxylamine, which can be stored for extended periods and released via heat, integrated into portable inhalation devices for controlled NO delivery.
Provides portable, stable, and safe delivery of nitric oxide for treating pulmonary disorders and antimicrobial applications with minimal loss of NO delivery activity, maintaining purity and controlled release profiles.